News
Gold Royalty Reports Third Quarter Results; Achieves Record Revenue and Adjusted EBITDA
Vancouver, British Columbia – November 5, 2025 – Gold Royalty Corp. (“Gold Royalty” or the “Company”) (NYSE American: GROY) (- https://www.commodity-tv.com/play/gold-royalty-ceo-on-record-rev
Gold Royalty Adopts Shareholder Rights Plan
Board and Special Committee act to protect and maximize value for shareholders
Vancouver, British Columbia – November 5, 2025 – Gold Royalty Corp. (“Gold
MAX Power begins historic drilling of Canada´s first-ever Natural Hydrogen well
This news release is not for distribution to U.S. newswire services for dissemination in the United States.
The Lawson Target Exhibits All Five Key Elements for a Potential Natural Hydrogen
UniDoc to Exhibit at ANCI 2025 in Bologna, November 12–14
VANCOUVER, BC / November 7, 2025 / UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) (“UniDoc” or the “Company”) will attend and exhibit at the 42nd Annual ANCI Assembly in Bologna,
Terra Clean Provides Corporate Update
Vancouver B.C., November 7, 2025 – TERRA CLEAN ENERGY CORP. (“Terra” or the “Company”) (CSE: TCEC, OTCQB: TCEFF, FSE: C9O0) is pleased to announce that it has scheduled its annual general
First Phosphate Announces Non-Brokered Private Placement to Accommodate Existing Investor
THIS NEWS RELEASE IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES
Saguenay, Quebec – November 7, 2025 – First Phosphate Corp. (“First Phosphate” or the “Company”) (CSE: PHOS) (OTCQX:
Uranium Energy Corp Applauds U.S. Government’s Designation of Uranium as a Critical Mineral
Addition of uranium to the U.S. Geological Survey Critical Minerals List marks a major step toward revitalizing U.S. uranium mining and rebuilding America’s nuclear fuel supply chain
Corpus
Defence Announces Successful Presentation at the World ADC Conference in San Diego and Plans to Expand Evaluation of Accum in Commercial and Pipeline ADCs
Montreal, QC, Canada, November 6th, 2025 - Defence Therapeutics Inc. (“Defence” or the “Company”), a leading biotechnology company pioneering next-generation antibody-drug conjugate (“ADC”),
HEALWELL Achieves Record Q3 Revenue Growth Now as a Pure-Play Global SaaS, Services & AI Company for Health Systems and Life Sciences
- HEALWELL achieved quarterly revenue from continuing operations of $30.4 million in Q3-2025, an
Outcrop Silver Announces Conditional Approval to Graduate to TSX
November 6, 2025 – Outcrop Silver & Gold Corporation (TSXV:OCG, OTCQX:OCGSF, DE:MRG) (“Outcrop Silver” or the “Company”) is pleased to announce that it has received conditional approval to
ZenaTech Invited to Present at Two Exclusive Investor Events in Palm Beach, Florida including at The Mar-a-Lago Club
Vancouver, British Columbia – November 6, 2025 – ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a business technology solution provider specializing in AI-driven drones,
First American Announces Private Placement of Flow-Through Shares
- NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES -
Vancouver, BC, November 6, 2025 – First American Uranium Inc. (CSE: NIOB) (FSE: IOR) (OTCQB: NIOMF) (“First
MAX Power strengthens board to support next phase of growth
This news release is not for distribution to U.S. newswire services for dissemination in the United States.
Saskatchewan Energy Leader Tom Kishchuk, Executive Director of the Global
Fortuna Reports Results for the Third Quarter of 2025
(All amounts are expressed in US dollars, tabular amounts in millions, unless otherwise stated)
Vancouver, November 5, 2025: Fortuna Mining Corp. (NYSE: FSM | TSX: FVI) (“Fortuna” or the
OR Royalties Reports Q3 2025 Results
Record Quarterly Revenues and an 87% Year-Over-Year Increase in Cash Flows from Operating Activities to $64.6 Million
Montréal, November 5, 2025 – OR
OR Royalties Declares Fourth Quarter 2025 Dividend
(Montreal, November 5, 2025) - OR Royalties Inc. (the “Company” or “OR Royalties”) (OR: TSX & NYSE) is pleased to announce that the Board of Directors has approved a fourth quarter 2025
Manganese X Energy Commends New Brunswick’s Vision for Comprehensive Minerals’ Strategy
Montreal, Quebec – November 06, 2025 – Manganese X Energy Corp. (TSXV: MN) (FSE: 9SC) (TRADEGATE: 9SC) (OTCQB: MNXXF) is pleased to commend the Government of New Brunswick for advancing a
Sterling Metals Announces Fully Allocated Private Placement Of Units And Charity Flow Through Units
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
November 5, 2025 – Toronto, Ontario – Sterling Metals Corp. (TSXV: SAG, OTCQB: SAGGF)
Loar Holdings Inc. Announces Date and Time for Third Quarter 2025 Earnings Conference Call
WHITE PLAINS, NY / ACCESS Newswire / November 5, 2025 / Loar Holdings Inc. (NYSE:LOAR), will report Q3 2025 earnings before the market opens on Wednesday, November 12, 2025.
A conference
Terra Clean Closes $2.5 Million Life Offering
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Vancouver B.C., November 5, 2025 – TERRA CLEAN ENERGY CORP. (“Terra” or the “Company”)
First Majestic Announces Financial Results for Q3 2025 and Quarterly Dividend Payment
Vancouver, BC, Canada - First Majestic Silver Corp. (NYSE:AG) (TSX:AG) (FSE:FMV) (the "Company" or “First Majestic”) is pleased to announce the Company’s
Universal Digital Announces Strategic Partnership with Crypto.com
Vancouver, British Columbia – November 5, 2025 – Universal Digital Inc. (“Universal Digital” or the “Company”) (CSE: LFG, OTCQB: LFGMF, FSE: 8R20) is pleased to announce it has entered into a
Kingman Minerals Prepares for Drilling at High-Grade Mohave Project amid Record Gold Prices
Vancouver, British Columbia – 11.05.25 – Kingman Minerals Ltd. (TSXV: KGS) (OTCQB: KGSSF) (Frankfurt: 47A)(“Kingman” or the “Company”) is pleased to update shareholders on the
Nexus Appointed by Timor-Leste to Promote Second Licensing Round
5 November 2025 - Aspermont (ASX:ASP, FRA:00W), the global leader in B2B media for the resource sectors, continues to accelerate the growth of Nexus, its strategic marketing and
Thiogenesis Reports Positive Interim Phase 2 Trial Results for MELAS and Announces Pipeline Advancements in Leigh Syndrome and Cystinosis
Trial achieved biological proof-of-concept, dose discovery and biomarker improvement
San Diego, California, November 4, 2025 – Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF)

